Insmed IncINSM
Price$108.59

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $1.1B+212.8% YoYTTM through 30 Jun 2026
Net Income -$875.3MTTM through 30 Jun 2026
Free Cash Flow -$807.7MTTM through 30 Jun 2026

Margins

Current
EBITDA Margin-73.8%
Operating Margin-73.9%
Net Margin-76.9%

Returns

-115.6%ROE
-41.6%ROA

Balance Sheet Health

Debt / Equity0.72x
Current Ratio3.72x
Net Debt-$1.3Mnet cash position
Cash & Equivalents$544.8M

Quality Metrics

Altman Z-Score7.80
Piotroski F-Score4 / 9
FCF Margin-71.0%
Rule of 40-12.2
Earnings-Beat Rate25.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $606.4M
Diluted EPS-$4.12TTM
'19'20'21'22'23'24'25
FY2025: $-6.42

Dividend

No dividend

Capital Allocation

R&D Spend$860.8M
Capex Intensity2.5%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.